Market Overview

Hypogonadism | A Pipeline Analysis Report 2018 | Technavio


Technavio has announced their latest pipeline analysis report on the hypogonadism
. The report includes a detailed analysis of the pipeline
molecules under investigation within the defined data collection period
to treat hypogonadism.

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for hypogonadism, including a  ...

Technavio has published a new report on the drug development pipeline for hypogonadism, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Hypogonadism: Market overview

When there is less or no secretion of the sex hormones, it leads to
various changes in the secondary sexual characteristics. This condition
is termed as hypogonadism. Secondary sexual characteristics include
breast development in females and testicular development in males.
Therefore, the production of sex hormones affects the menstrual cycle
and sperm production. The glands that produce the sex hormones are known
as gonads. Hence, hypogonadism is also termed as gonad deficiency.

According to a senior market research analyst at Technavio, "Hypogonadism
is largely seen in middle-aged and older-aged individuals. The incidence
of hypogonadism increases with age. There is an increase in the number
of people aged 65 years and above in the US. This rise in number of
people belonging to the higher age group may lead to an increase in the
incidences of hypogonadism. As a result, the increasing incidences of
hypogonadism is expected to boost the drug development for hypogonadism."

Hypogonadism: Segmentation analysis

This pipeline analysis report segments the hypogonadism market based on
therapies employed (monotherapy and combination therapy), RoA (oral,
nasal, subcutaneous, topical, and transdermal), therapeutic modality
(small molecule, fusion protein and peptide), targets (androgen
receptor, androgen+estrogen receptor, estrogen receptor, and
follicle-stimulating hormone receptor), MoA (androgen receptor agonist,
androgen+estrogen receptor agonist, estrogen receptor
antagonist/agonist, and follicle-stimulating hormone receptor),
geographical segmentation (US, Canada, and Europe) and recruitment
status (active, not recruiting, completed, not yet recruiting, and
recruiting). It provides an in-depth analysis of the prominent factors
influencing the market, including drivers, opportunities, trends, and
industry-specific challenges.

Around 67% of the molecules that are being investigated for the
treatment of hypogonadism are androgen receptor agonists.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!